Audrey with her books
Audrey with her books


living with mild
Alzheimer's dementia*

Slow progression with LEQEMBI

In an 18-month study of people with early Alzheimer’s disease, LEQEMBI was proven to slow the progression of early Alzheimer's disease. Even though you cannot stop Alzheimer’s disease from getting worse, you can take steps to slow how fast it progresses. Early treatment with LEQEMBI can help you keep playing the roles you have for longer.

How progression was measured

A tool called the Clinical Dementia Rating (CDR) scale measured progression by asking people how Alzheimer’s disease impacted different abilities listed below. LEQEMBI was not proven to individually impact each of these abilities.

Light bulb icon


Purple figure with icons for different activities swirling around their head

Staying active

Signpost icon

Knowing your way around

Purple task list icon

Completing daily tasks

Purple puzzle icon


Figure with purple flag hanging above them

Doing activities independently

Who was included in the study?

Group of people icon

1,795 people

Age 50 and age 90 icon

Ages 50 to 90

Diverse world icon

From different ethnic and racial backgrounds

Brain icon

With mild cognitive impairment (MCI) or mild dementia due to Alzheimer’s disease

The study was divided into 2 groups. One group took LEQEMBI (898 people), and the other group did not take LEQEMBI (897 people).

Lola and her husband, David, embracing each other
Lola and her husband, David, embracing each other

There were moments in my journey that I go up and down, and then I think, well,


Patient shown is not taking LEQEMBI.


living with mild Alzheimer’s dementia,
and her husband, David